Show simple item record

dc.contributor.authorLührmann, Anke
dc.contributor.authorDeiters, Ursula
dc.contributor.authorSkokowa, Julia
dc.contributor.authorHanke, Michaela
dc.contributor.authorGessner, Johannes E.
dc.contributor.authorMühlradt, Peter F.
dc.contributor.authorPabst, Reinhard
dc.contributor.authorTschernig, Thomas
dc.date.accessioned2007-02-20T12:50:48Z
dc.date.available2002-07en_US
dc.date.available2007-02-20T12:50:48Z
dc.date.issued2002-07en_US
dc.identifier.citationInfection and Immunity 2002 70(7):3785-3792en_US
dc.identifier.issn0019-9567en_US
dc.identifier.issn1098-5522en_US
dc.identifier.pmid12065522en_US
dc.identifier.doi10.1128/IAI.70.7.3785-3792.2002en_US
dc.identifier.urihttp://hdl.handle.net/10033/8598
dc.language.isoen_US
dc.publisherAmerican Society for Microbiologyen_US
dc.rightsCopyright © 2002, American Society for Microbiologyen_US
dc.titleIn Vivo Effects of a Synthetic 2-Kilodalton Macrophage-Activating Lipopeptide of Mycoplasma fermentans after Pulmonary Applicationen_US
dc.identifier.pmcid128036en_US
dc.format.digYES
refterms.dateFOA2018-06-13T04:06:35Z


Files in this item

Thumbnail
Name:
Lührmann et al_final.pdf
Size:
558.2Kb
Format:
PDF
Description:
free text from BMC's repository ...

This item appears in the following Collection(s)

Show simple item record